Real-world experience with CLAIRYG® 50 mg/mL (intravenous immunoglobulin) in children under 12 years with primary immunodeficiency or immmune thrombocytopenia: a post-approval safe...

por Mahlaoui, Nizar, Fouyssac, Fanny, Mazingue, Françoise, Mallebranche, Coralie, Barthez-Toullec, Malika, Denti, Lamia, Ruhier, Kalaivani, André-Bonnet, Marie-Hélène, Marie-Cardine, Aude, Aladjidi, Nathalie, Stephan, Jean-Louis
Publicado 2023